• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青蒿素类

Artemisinins.

作者信息

Woodrow C J, Haynes R K, Krishna S

机构信息

Department of Cellular and Molecular Medicine, Infectious Diseases, St George's Hospital Medical School, Tooting, London, UK.

出版信息

Postgrad Med J. 2005 Feb;81(952):71-8. doi: 10.1136/pgmj.2004.028399.

DOI:10.1136/pgmj.2004.028399
PMID:15701735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1743191/
Abstract

Artemisinins were discovered to be highly effective antimalarial drugs shortly after the isolation of the parent artemisinin in 1971 in China. These compounds combine potent, rapid antimalarial activity with a wide therapeutic index and an absence of clinically important resistance. Artemisinin containing regimens meet the urgent need to find effective treatments for multidrug resistant malaria and have recently been advocated for widespread deployment. Comparative trials of artesunate and quinine for severe malaria are in progress to see if the persistently high mortality of this condition can be reduced.

摘要

1971年中国分离出青蒿素母体后不久,人们发现青蒿素类药物是高效抗疟药。这些化合物兼具强效、快速的抗疟活性,治疗指数宽且无临床上重要的耐药性。含青蒿素的治疗方案满足了寻找耐多药疟疾有效治疗方法的迫切需求,最近已被提倡广泛应用。青蒿琥酯和奎宁用于治疗重症疟疾的对比试验正在进行,以了解这种疾病持续居高不下的死亡率是否能够降低。

相似文献

1
Artemisinins.青蒿素类
Postgrad Med J. 2005 Feb;81(952):71-8. doi: 10.1136/pgmj.2004.028399.
2
Artemisinins in malaria treatment in the UK.青蒿素在英国疟疾治疗中的应用。
Drug Ther Bull. 2010 Nov;48(11):129-32. doi: 10.1136/dtb.2010.11.0057.
3
Artemisinin derivatives and malaria: useful, in combination with other antimalarials.青蒿素衍生物与疟疾:与其他抗疟药物联合使用时有效。
Prescrire Int. 2008 Aug;17(96):162-8.
4
Intravenous artesunate for the treatment of severe malaria.静脉注射青蒿琥酯治疗重症疟疾。
Ann Pharmacother. 2010 Jul-Aug;44(7-8):1250-8. doi: 10.1345/aph.1M732. Epub 2010 Jun 15.
5
Intravenous artesunate for severe malaria.静脉注射青蒿琥酯治疗重症疟疾。
Prescrire Int. 2008 Aug;17(96):168-70.
6
Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.阿奇霉素联合青蒿琥酯或奎宁治疗成人非复杂性恶性疟:泰国一项随机2期临床试验
Clin Infect Dis. 2006 Nov 15;43(10):1264-71. doi: 10.1086/508175. Epub 2006 Oct 12.
7
Artemether for severe malaria: a meta-analysis of randomized clinical trials.蒿甲醚治疗重症疟疾:随机临床试验的荟萃分析
Clin Infect Dis. 1999 Mar;28(3):597-601. doi: 10.1086/515148.
8
Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.青蒿琥酯-克林霉素与奎宁-克林霉素治疗恶性疟原虫疟疾的随机对照试验
Clin Infect Dis. 2005 Jun 15;40(12):1777-84. doi: 10.1086/430309. Epub 2005 May 3.
9
[Treatment of pediatric malaria in Africa: act at issue].[非洲儿童疟疾的治疗:争议焦点]
Med Trop (Mars). 2006 Jun;66(3):292-4.
10
Current perspectives on the mechanism of action of artemisinins.青蒿素作用机制的当前观点。
Int J Parasitol. 2006 Dec;36(14):1427-41. doi: 10.1016/j.ijpara.2006.07.011. Epub 2006 Sep 12.

引用本文的文献

1
Recent Advancement in Drug Development for Treating Malaria using Herbal Medicine and Nanotechnological Approach.利用草药和纳米技术方法治疗疟疾的药物研发最新进展
Curr Pharm Des. 2025;31(3):203-218. doi: 10.2174/0113816128321468240828103439.
2
Molecular Interactions Identified by Two-Dimensional Analysis-Detailed Insight into the Molecular Interactions of the Antimalarial Artesunate with the Target Structure β-Hematin by Means of 2D Raman Correlation Spectroscopy.二维分析鉴定的分子相互作用 - 通过二维拉曼相关光谱技术深入了解抗疟药青蒿琥酯与靶结构β-血影蛋白的分子相互作用。
Anal Chem. 2023 Aug 29;95(34):12719-12731. doi: 10.1021/acs.analchem.3c01415. Epub 2023 Aug 16.
3
Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles.人细胞色素 P450 家族 1、2、3 作为药物代谢基因,重点介绍其抗疟和抗结核药物及常见的非洲等位基因。
Int J Mol Sci. 2023 Feb 8;24(4):3383. doi: 10.3390/ijms24043383.
4
Inflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: A comprehensive overview.炎性小体作为创伤性脑损伤及相关神经退行性疾病的生物标志物和治疗靶点:全面综述。
Neurosci Biobehav Rev. 2023 Jan;144:104969. doi: 10.1016/j.neubiorev.2022.104969. Epub 2022 Nov 22.
5
Autophagy Underlies the Proteostasis Mechanisms of Artemisinin Resistance in P. falciparum Malaria.自噬是青蒿素抗疟原虫耐药性的蛋白稳态机制的基础。
mBio. 2022 Jun 28;13(3):e0063022. doi: 10.1128/mbio.00630-22. Epub 2022 Apr 14.
6
Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria.疟疾治疗与控制的当前挑战及基于纳米技术的药物策略
Parasite Epidemiol Control. 2022 Feb 16;17:e00244. doi: 10.1016/j.parepi.2022.e00244. eCollection 2022 May.
7
Peroxide Antimalarial Drugs Target Redox Homeostasis in Infected Red Blood Cells.过氧化物抗疟药物靶向感染红细胞中的氧化还原稳态。
ACS Infect Dis. 2022 Jan 14;8(1):210-226. doi: 10.1021/acsinfecdis.1c00550. Epub 2022 Jan 5.
8
studies on the biochemical indices of infected mice treated with leaf and root extracts.用叶和根提取物治疗感染小鼠的生化指标研究。
Afr Health Sci. 2020 Dec;20(4):1698-1709. doi: 10.4314/ahs.v20i4.21.
9
Antimalarial Drug Resistance and Implications for the WHO Global Technical Strategy.抗疟药物耐药性及其对世界卫生组织全球技术战略的影响。
Curr Epidemiol Rep. 2021;8(2):46-62. doi: 10.1007/s40471-021-00266-5. Epub 2021 Mar 14.
10
Fungal Endophytes as Efficient Sources of Plant-Derived Bioactive Compounds and Their Prospective Applications in Natural Product Drug Discovery: Insights, Avenues, and Challenges.作为植物源生物活性化合物的高效来源的真菌内生菌及其在天然产物药物发现中的潜在应用:见解、途径与挑战
Microorganisms. 2021 Jan 19;9(1):197. doi: 10.3390/microorganisms9010197.

本文引用的文献

1
Artemisinins: activities and actions.青蒿素:活性与作用
Microbes Infect. 2004 Nov;6(14):1339-46. doi: 10.1016/j.micinf.2004.09.002.
2
Artemisinins: mechanisms of action and potential for resistance.青蒿素:作用机制与耐药性潜力
Drug Resist Updat. 2004 Aug-Oct;7(4-5):233-44. doi: 10.1016/j.drup.2004.07.001.
3
Identification of an antimalarial synthetic trioxolane drug development candidate.一种抗疟合成三氧杂环乙烷药物开发候选物的鉴定。
Nature. 2004 Aug 19;430(7002):900-4. doi: 10.1038/nature02779.
4
Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.巴布亚新几内亚患单纯性疟疾儿童使用青蒿琥酯栓剂后青蒿琥酯和双氢青蒿素的处置情况。
Antimicrob Agents Chemother. 2004 Aug;48(8):2966-72. doi: 10.1128/AAC.48.8.2966-2972.2004.
5
Antimalarial combinations.抗疟药物组合
Lancet. 2004;364(9430):285-94. doi: 10.1016/S0140-6736(04)16680-4.
6
A medicinal chemistry perspective on artemisinin and related endoperoxides.从药物化学角度看青蒿素及相关内过氧化物。
J Med Chem. 2004 Jun 3;47(12):2945-64. doi: 10.1021/jm030571c.
7
Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study.非洲儿童和成人中,直肠用青蒿琥酯与胃肠外奎宁在中度严重疟疾初始治疗中的疗效比较:一项随机研究。
Lancet. 2004 May 15;363(9421):1598-605. doi: 10.1016/S0140-6736(04)16203-X.
8
Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether.与使用复方蒿甲醚治疗单纯性恶性疟相关的听力测定变化
Trans R Soc Trop Med Hyg. 2004 May;98(5):261-7; discussion 268-9. doi: 10.1016/j.trstmh.2003.11.001.
9
Antimalarial drug resistance.抗疟药耐药性。
J Clin Invest. 2004 Apr;113(8):1084-92. doi: 10.1172/JCI21682.
10
Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: A review.开发基于青蒿素的联合用药治疗耐药性恶性疟原虫疟疾:综述
J Postgrad Med. 2004 Jan-Mar;50(1):40-4.